Dasatinib
Showing 1 - 25 of 403
Acute Myeloid Leukemia Trial (Dasatinib)
Not yet recruiting
- Acute Myeloid Leukemia
- Dasatinib
- (no location specified)
Sep 20, 2023
Myeloma Multiple Trial in Chia (Dasatinib 100 MG)
Not yet recruiting
- Myeloma Multiple
- Dasatinib 100 MG
-
Chia, Cundinamarca, ColombiaCAIMED
Jul 12, 2023
Lymphoblastic Leukemia Trial in Palo Alto (Dasatinib)
Not yet recruiting
- Lymphoblastic Leukemia
- Dasatinib
-
Palo Alto, CaliforniaStanford University
Aug 14, 2023
Schizophrenia, Treatment Resistant Depression, Aging, Premature Trial in Saint Louis (Dasatinib + quercetin)
Not yet recruiting
- Schizophrenia
- +2 more
- Dasatinib + quercetin
-
Saint Louis, MissouriWashington University School of Medicine
Apr 28, 2023
Leukemia, Myelogenous, Chronic Trial in Changchun (CTTQ Dasatinib tablet, Sprycel Dasatinib tablet)
Completed
- Leukemia, Myelogenous, Chronic
- CTTQ Dasatinib tablet
- Sprycel Dasatinib tablet
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Dec 7, 2022
Solid Tumors Trial run by the National Cancer Institute (NCI) (Bevacizumab, Dasatinib)
Completed
- Solid Tumors
- Bevacizumab
- Dasatinib
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 19, 2023
Head and Neck Squamous Cell Carcinomas Trial (Tislelizumab + Dasatinib + Quercetin, surgery)
Not yet recruiting
- Head and Neck Squamous Cell Carcinomas
- Tislelizumab + Dasatinib + Quercetin
- surgery
- (no location specified)
Feb 2, 2023
HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)
Not yet recruiting
- HIV Infection Primary
- Dasatinib 70 mg
- Placebo
-
Badalona, Barcelona, SpainHospital Universitari Germans Trias i Pujol
Mar 9, 2023
Drug-drug Interaction Study Trial in Hyderabad (SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole
Completed
- Drug-drug Interaction Study
- SPRYCEL® (dasatinib) 100 mg Film-Coated Tablets in combination with Omeprazole Delayed-Release Capsules USP, 40 mg
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Nov 20, 2023
Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)
Completed
- Advanced Cancer
- Dasatinib
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 21, 2022
Chronic Myeloid Leukemia, Chronic Phase Trial in Monterrey (Dasatinib Pill, Ketoconazole Pill)
Recruiting
- Chronic Myeloid Leukemia, Chronic Phase
- Dasatinib Pill
- Ketoconazole Pill
-
Monterrey, Nuevo Leon, MexicoHospital Universitario Dr. José Eleuterio González
Nov 25, 2022
Glioma, High Grade Glioma, Pontine Tumors Trial in Ann Arbor (Dasatinib, Everolimus)
Terminated
- Glioma
- +2 more
- Dasatinib
- Everolimus
-
Ann Arbor, MichiganUniversity of Michigan Cancer Center
Sep 26, 2022
NAFLD, NASH With Fibrosis, Liver Fibrosis Trial (Dasatinib 100 MG + Quercetin (1250 MG), Placebo)
Not yet recruiting
- NAFLD
- +2 more
- Dasatinib 100 MG + Quercetin (1250 MG)
- Placebo
- (no location specified)
Aug 16, 2022
Among CP-CML Participants Initiating Dasatinib inReal Life
Completed
- Chronic Myeloid Leukemia
- Non-Interventional
-
Paris, FranceLocal Institution
Jun 17, 2022
Symptomatic COVID-19 Infection Laboratory-Confirmed Trial in Los Angeles (Dasatinib Anhydrous, Placebo Administration)
Withdrawn
- Symptomatic COVID-19 Infection Laboratory-Confirmed
- Dasatinib Anhydrous
- Placebo Administration
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Biological Availability Trial in Hyderabad (Dasatinib ASD 100 mg, Dasatinib 140 MG [Sprycel])
Completed
- Biological Availability
- Dasatinib ASD 100 mg
- Dasatinib 140 MG [Sprycel]
-
Hyderabad, IndiaQPS Bioserve India Pvt Limited
Jun 28, 2022
Advanced Cancers Trial in Houston (Crizotinib, Dasatinib)
Completed
- Advanced Cancers
- Crizotinib
- Dasatinib
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jun 29, 2022
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) Recurrent, Lymphoblastic
Not yet recruiting
- Acute Lymphoblastic Leukemia
- +4 more
- Dasatinib
- +5 more
-
Utrecht, NetherlandsPrincess Máxima Center for Pediatric Oncology
Feb 20, 2023
Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia
- +3 more
- Dasatinib
- Decitabine and Cedazuridine
-
Houston, TexasM D Anderson Cancer Center
Aug 11, 2022
Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic
Recruiting
- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
- Dasatinib
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 24, 2022
Acute,Leukemia, Lymphoid Trial in Tianjin (Dasatinib, prednisone, cyclophosphamide)
Completed
- Acute,Leukemia, Lymphoid
- Dasatinib
- +12 more
-
Tianjin, Tianjin, ChinaInstitute of Hematology & Blood Diseases Hospital
Aug 2, 2022
Waldenstrom Macroglobulinemia, DASATINIB Trial in Boston (Dasatinib)
Recruiting
- Waldenstrom Macroglobulinemia
- DASATINIB
- Dasatinib
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 22, 2022
Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)
Recruiting
- Chronic Myeloid Leukemia in Chronic Phase
- Flumatinib
- Dasatinib
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Jul 26, 2022
Acute Lymphoblastic Leukemia Trial in New York (Ruxolitinib, Dasatinib, Dexamethasone)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- Ruxolitinib
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jul 25, 2022
Pharmacokinetics, Drug Interactions Trial in Dilworth (Dasatinib ASD, Omeprazole 40 MG)
Completed
- Pharmacokinetics
- Drug Interactions
- Dasatinib ASD
- Omeprazole 40 MG
-
Dilworth, MinnesotaAXIS Clinicals
Jun 21, 2022